Percentage of patients myelinated in each region per the 2 observers
| SE T2WI | SE T1WI | GRE T1WI | ||||
|---|---|---|---|---|---|---|
| Observer 1 | Observer 2 | Observer 1 | Observer 2 | Observer 1 | Observer 2 | |
| AC | 36.4% (4/11) | 0% (0/11) | 0% (0/11) | 0% (0/11) | 0% (0/11) | 0% (0/11) |
| ALIC | 0% (0/11) | 0% (0/11) | 0% (0/11) | 0% (0/11) | 0% (0/11) | 0% (0/11) |
| BIC | 54.5% (6/11) | 100% (11/11) | 9% (1/11) | 45.5% (5/11) | 36.4% (4/11) | 100% (11/11) |
| CCS | 90.9% (10/11)a | 90.9% (10/11)a | 9% (1/11) | 45.5% (5/11) | 18.2% (2/11) | 90.9% (10/11) |
| CNV | 63.6% (7/11) | 100% (11/11) | 0% (0/11) | 45.5% (5/11) | 81.8% (9/11) | 90.9% (10/11) |
| CST | 0% (0/11) | 36.4% (4/11) | 27.3% (3/11) | 45.5% (5/11) | 36.4% (4/11) | 81.8% (9/11) |
| DSCP | 100% (11/11)a | 100% (11/11)a | 27.3% (3/11) | 81.8% (9/11) | 100% (11/11)a | 100% (11/11)a |
| HC | 81.8% (9/11) | 72.7% (8/11) | 54.5% (6/11) | 63.6% (7/11) | 72.7% (8/11) | 72.7% (8/11) |
| ICP | 90.9% (10/11)a | 100% (11/11)a | 72.7% (8/11) | 63.6% (7/11) | 90.9% (10/11)a | 100% (11/11)a |
| LGN | 18.2% (2/11) | 63.6% (7/11) | 0% (0/11) | 27.3% (3/11) | 27.3% (3/11) | 72.7% (8/11) |
| LL | 100% (11/11)a | 100% (11/11)a | 54.5% (6/11) | 81.8% (9/11) | 100% (11/11)a | 100% (11/11)a |
| ML | 81.8% (9/11) | 100% (11/11) | 9.1% (1/11) | 81.8% (9/11) | 90.9% (10/11)a | 100% (11/11)a |
| MLF | 27.3% (3/11) | 36.4% (4/11) | 0% (0/11) | 0% (0/11) | 0% (0/11) | 9% (1/11) |
| ON | 45.5% (5/11) | 18.2% (2/11) | 9% (1/11) | 9% (1/11) | 72.7% (8/11) | 27.3% (3/11) |
| OR | 0% (0/11) | 0% (0/11) | 0% (0/11) | 0% (0/11) | 0% (0/11) | 0% (0/11) |
| OT | 81.8% (9/11) | 63.6% (7/11) | 27.3% (3/11) | 27.3% (3/11) | 45.5% (5/11) | 36.4% (4/11) |
| PC | 18.2% (2/11) | 9.1% (1/11) | 0% (0/11) | 0% (0/11) | 0% (0/11) | 0% (0/11) |
| PD | 63.6% (7/11) | 100% (11/11) | 18.2% (2/11) | 27.3% (3/11) | 90.9% (10/11)a | 100% (11/11)a |
| PLIC | 81.8% (9/11) | 90.9% (10/11) | 81.8% (9/11) | 81.8% (9/11) | 100% (11/11)a | 100% (11/11)a |
| PRC | 81.8% (9/11) | 100% (11/11) | 0% (0/11) | 45.5% (5/11) | 18.2% (2/11) | 72.7% (8/11) |
| SCP | 81.8% (9/11) | 90.9% (10/11) | 36.4% (4/11) | 54.5%(6/11) | 90.9% (10/11)a | 100% (11/11)a |
| STV | 90.9% (10/11)a | 100% (11/11)a | 18.2% (2/11) | 36.4% (4/11) | 72.7% (8/11) | 63.6% (7/11) |
Note:—AC indicates anterior commissure; ALIC, anterior limb of the internal capsule; BIC, brachium of the inferior colliculus; CCS, corpus callosum splenium; CNV, cranial nerve V; CST, corticospinal tracts; HC, habenular commissure; LGN, lateral geniculate nucleus; LL, lateral lemniscus; ML, medial lemniscus; MLF, medial longitudinal fasciculus; ON, optic nerve; OR, optic radiations; OT, optic tracts; PC, posterior commissure; PRC, perirolandic cortex; PD, pyramidal decussation; SCP, superior cerebellar peduncle; STV, spiral tract/nucleus of cranial nerve V.
↵a Structures that both reviewers and observers found to be myelinated in 90%–100% of term-equivalent patients.